Hedge Funds Are Betting On Rigel Pharmaceuticals, Inc. (RIGL)

Page 2 of 2
Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) 16 0 1
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) 10 0 4
Endocyte, Inc. (NASDAQ:ECYT) 11 1 6
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) 9 0 1
Keryx Biopharmaceuticals (NASDAQ:KERX) 17 0 2

With the results shown by Insider Monkey’s time-tested strategies, everyday investors should always keep an eye on hedge fund and insider trading sentiment, and Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shareholders fit into this picture quite nicely.

Click here to learn why you should track hedge funds

Page 2 of 2